Switch to:
Novo Nordisk A/S (NYSE:NVO)
EV/EBITDA
17.56 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Novo Nordisk A/S's enterprise value is $119,041 Mil. Novo Nordisk A/S's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2013 was $6,339 Mil. Therefore, Novo Nordisk A/S's EV/EBITDA ratio for today is 17.56.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Novo Nordisk A/S's stock price is $44.15. Novo Nordisk A/S's earnings per share for the trailing twelve months (TTM) ended in Dec. 2013 was $1.28. Therefore, Novo Nordisk A/S's P/E Ratio for today is 26.00.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Novo Nordisk A/S's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=119040.615/6339.10136248
=18.78

Novo Nordisk A/S's current Enterprise Value is $119,041 Mil.
Novo Nordisk A/S's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2013 was 1376.13556953 (Mar. 2013 ) + 1570.37557038 (Jun. 2013 ) + 1538.60226857 (Sep. 2013 ) + 1853.98795401 (Dec. 2013 ) = $6,339 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Novo Nordisk A/S's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=44.15/1.28234956654
=34.43

Novo Nordisk A/S's share price for today is $44.15.
Novo Nordisk A/S's Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2013 was 0.383647798742 (Mar. 2013 ) + 0.436995436995 (Jun. 2013 ) + 0.437614343213 (Sep. 2013 ) + 0.024091987589 (Dec. 2013 ) = $1.28.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda 4.865.096.1514.7110.6310.4513.5715.3812.972.61

Novo Nordisk A/S Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebitda 14.8015.3815.8415.8613.5612.9712.6711.5813.772.61
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide